Home / Therapies / Devices (page 24)

Devices

Medical Devices for Diabetes Management: The following articles answer key questions about the use and application of medical devices for diabetes patient care including:
– What do they do and how?
– What medical device options are available for diabetes management?
– When should a medical device be considered?

Handbook of Diabetes, 4th Edition, Excerpt #10: Management of Type 2 Diabetes

handbook-of-diabetes-image

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Lifestyle modification The starting points and mainstays of treatment for type 2 diabetes are diet and other modifications of lifestyle, such as increasing exercise and stopping smoking (Figure 11.1). The major aims are to reduce the weight of obese patients and …

Read More »

Handbook of Diabetes, 4th Edition, Excerpt #9: Management of Type 1 Diabetes

handbook-of-diabetes-image

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Modern management of type 1 diabetes comprises a package of measures including multiple daily injections for a more physiological insulin replacement; assessment of glycaemic control using blood glucose self-monitoring as well as clinic tests such as glycated haemoglobin (HbA1c); insulin dosage …

Read More »

Handbook of Diabetes, 4th Edition, Excerpt #8: Diabetes Control and Its Measurement

handbook-of-diabetes-image

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Diabetic control ‘defines the extent to which the metabolism in the person with diabetes differs from that in the person without diabetes. Measurement usually focuses on blood glucose: ‘good ‘ control implies maintenance of near-normal blood glucose concentrations throughout the day. …

Read More »

Handbook of Diabetes, 4th Edition, Excerpt #6: Epidemiology and Aetiology of Type 2 Diabetes

handbook-of-diabetes-image

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP   Epidemiological studies of diabetes prevalence are often based upon age and self-reported diagnosis. Consequently differentiating type 1 and type 2 patients in population studies is difficult. The most recent authoritative review of global prevalence published by the International Diabetes Federation (IDF) …

Read More »

Handbook of Diabetes, 4th Edition, Excerpt #5: Epidemiology and aetiology of type 1 diabetes

handbook-of-diabetes-image

  Rudy Bilous MD, FRCP Richard Donnelly MD, PHD, FRCP, FRACP   The most common cause of type 1 diabetes (over 90% of cases) is T cell-mediated autoimmune destruction of the islet beta cells leading to a failure of insulin production. The exact aetiology is complex and still imperfectly understood. However, it …

Read More »

Terry Gregg, CEO, Dexcom: The Increasing Use of CGM

Terry_Gregg

Terry Gregg, CEO, Dexcom, discusses the current landscape of reimbursement for CGM technology. Although insurance companies were initially slow to catch on for approving CGM devices for type 1’s, there has been a shift and approvals seem to be improving. He is also sees the overall market increasing as more …

Read More »